A detailed history of Caption Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 48,000 shares of MRNA stock, worth $1.89 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
48,000
Previous 30,000 60.0%
Holding current value
$1.89 Million
Previous $3.56 Million 9.97%
% of portfolio
0.06%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $710,280 - $1.26 Million
6,000 New
6,000 $1.08 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.93 Million - $4.98 Million
29,323 New
29,323 $3.06 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.